دورية أكاديمية
Polymorphism -433 C>T of the Osteopontin Gene is Associated with the Susceptibility to Develop Gliomas and their Prognosis in a Chinese Cohort
العنوان: | Polymorphism -433 C>T of the Osteopontin Gene is Associated with the Susceptibility to Develop Gliomas and their Prognosis in a Chinese Cohort |
---|---|
المؤلفون: | Zhipeng Shen, Bo Chen, Xuwei Hou, Peng Chen, Guoqiang Zhao, Jiajie Fan |
المصدر: | Cellular Physiology and Biochemistry, Vol 34, Iss 4, Pp 1190-1198 (2014) |
بيانات النشر: | Cell Physiol Biochem Press GmbH & Co KG, 2014. |
سنة النشر: | 2014 |
المجموعة: | LCC:Physiology LCC:Biochemistry |
مصطلحات موضوعية: | Prognosis, Gliomas, Polymorphism, Risk, Osteopontin, Physiology, QP1-981, Biochemistry, QD415-436 |
الوصف: | Aim: To investigate role of the Osteopontin (OPN) genetic polymorphisms in the susceptibility to gliomas and their prognosis. Methods: A total of 248 Chinese glioma patients and 281 age and sex matched healthy controls were recruited. The genetic polymorphisms at three loci, namely, -156 GG>G, -443 C>T and -66T>G, were determined. The log-rank test and Kaplan- Meier analysis were introduced to assess the effect of OPN gene polymorphisms on patient survival. Results: We found that the genotype frequencies of OPN -443 C>T polymorphism were significantly different between glioma patients and controls. Multivariable analyses showed a higher risk for gliomas in -443 CC genotype carriers compared to -443TT carriers (PT polymorphism was closely related to the gliomas' tumor grade. The -443 C>T polymorphism also affected the tumor OPN expression level, but not the serum OPN level. More importantly, the -443 C>T polymorphism was significantly associated with the prognosis of these patients regardless of their treatment status. The patients with -443CC genotype had a poorer prognosis than those with -443TT and -443CT genotypes. In contrast, the -156 G>GG and -66T>G polymorphisms were not associated with risk, clinical characteristics, or prognosis of gliomas. Conclusion: This study suggests that the -443C>T gene polymorphisms may be used as a molecular marker for glioma occurrence and clinical outcome in glioma patients. © 2014 S. Karger AG, Basel |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English |
تدمد: | 1015-8987 1421-9778 00036633 |
Relation: | http://www.karger.com/Article/FullText/366331; https://doaj.org/toc/1015-8987; https://doaj.org/toc/1421-9778 |
DOI: | 10.1159/000366331 |
URL الوصول: | https://doaj.org/article/5f0407b0a40f49749c9367a654c8c334 |
رقم الأكسشن: | edsdoj.5f0407b0a40f49749c9367a654c8c334 |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 10158987 14219778 00036633 |
---|---|
DOI: | 10.1159/000366331 |